News

Pfizer’s COVID-19 Candidate Has Moderate Side Effects

Pfizer has announced that participants in their phase III clinical trial had moderate side effects. More than 12,000 people have received a second round of the vaccine, with 29,000 enrolled in the trial. For phase III, Pfizer would like to increase enrollment to 44,000 including people as young as 16 and those with HIV and hepatitis C or B. Yourway’s primary and secondary packaging capabilities integrate seamlessly with our storage & distribution and premium courier services to enhance supply chain efficiency and facilitate shorter lead times compared to other clinical services and logistics companies.

Read More

Diverse Candidate Recruitment Remains Low

Although trials for COVID-19 vaccines have moved at “warped speed,” recruiting diverse candidates has posed a challenge for companies. According to the FDA, clinical trial enrollment among people of color is low, as there is a general mistrust of medical experimentation within the community. With a global presence, Yourway has clinical trial sites set up around the globe to reach participants of highly diverse backgrounds.

Read More

Atossa Therapeutics Reports Positive Safety Data

Read More

Pfizer’s Begins Clinical Trials for Antiviral

Read More

Oral COVID-19 Vaccine Candidate Cleared by FDA

Read More

Clinical Trial Data Integrity Questioned in Russian Trials

Read More

Brazilian Trials of Sinovac’s COVID-19 Vaccine Are Promising

Read More

COVID-19 Vaccine Trial Paused Due to Safety Concerns

Read More

FSD Pharma Files for Phase II Clinical Trials

Read More

Cynata Therapeutics Kicks Off Patient Enrollment

Read More

Federal Health Advisors Expect Four COVID-19 Vaccine Trials to Fail

Read More

Rutgers New Jersey as a COVID-19 Trial Site

Read More

Depending on Results, COVID-19 Vaccine Trials Could End Early

Read More

Steroids May Reduce Risk of Death in COVID-19 Patients

Read More

COVID-19 Vaccines from China and Russia Likely Ineffective

Read More
Media

Upcoming Event

World Vaccine Congress Washington DC 2020

September 27-29, 2020
Washington DC

Media

Articles

Staying Ahead of COVID-19

Open chat
Come chat with us!
Hello! How can I help you?